Analysis 
This analysis is a restriction of analysis 1a, only including the participants that chose the first drug in the randomisation sequence: amisulpride (n = 38), aripiprazole (n = 43) and olanzapine (n = 39). The results from model 1b showed no similar improvements of insight in the long-term phase for the amisulpride as detected in analysis #1a. However, a worsening in insight was found for the olanzapine group. Other results were found equal to the ones found in model 1a.